|
CSRNP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.142700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.840100E-02 |
| Normal-vs-Stage2 |
3.520300E-02 |
| Normal-vs-Stage3 |
9.917100E-03 |
| Normal-vs-Stage4 |
2.028100E-02 |
| Stage1-vs-Stage2 |
5.222800E-01 |
| Stage1-vs-Stage3 |
4.917000E-01 |
| Stage1-vs-Stage4 |
5.015800E-01 |
| Stage2-vs-Stage3 |
8.891400E-01 |
| Stage2-vs-Stage4 |
9.533600E-01 |
| Stage3-vs-Stage4 |
9.337000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.398600E-03 |
| Normal-vs-AfricanAmerican |
3.895500E-02 |
| Normal-vs-Asian |
9.981900E-02 |
| Caucasian-vs-AfricanAmerican |
8.116600E-01 |
| Caucasian-vs-Asian |
5.039500E-03 |
| AfricanAmerican-vs-Asian |
1.162290E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.359680E-03 |
| Normal-vs-Female |
1.630840E-01 |
| Male-vs-Female |
1.141510E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.326400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.711500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.578900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.058970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.925800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.727800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.835400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.872840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.670200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.852200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.743400E-01 |
| Normal-vs-Grade 2 |
7.740000E-02 |
| Normal-vs-Grade 3 |
1.135420E-03 |
| Normal-vs-Grade 4 |
1.389700E-02 |
| Grade 1-vs-Grade 2 |
1.915590E-01 |
| Grade 1-vs-Grade 3 |
3.167800E-02 |
| Grade 1-vs-Grade 4 |
5.613900E-02 |
| Grade 2-vs-Grade 3 |
5.635900E-02 |
| Grade 2-vs-Grade 4 |
2.654400E-01 |
| Grade 3-vs-Grade 4 |
7.966000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.436200E-02 |
| Normal-vs-ccB subtype |
4.690200E-02 |
| ccA subtype-vs-ccB subtype |
8.429600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.300400E-02 |
| Normal-vs-N1 |
3.249800E-01 |
| N0-vs-N1 |
9.231000E-01 |
|
|
